Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Shares Outstanding (2016 - 2025)

Collegium Pharmaceutical has reported Shares Outstanding over the past 10 years, most recently at $40.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $40.7 million for Q4 2025, up 2.75% from a year ago — trailing twelve months through Dec 2025 was $40.7 million (up 2.75% YoY), and the annual figure for FY2025 was $40.7 million, up 2.75%.
  • Shares Outstanding for Q4 2025 was $40.7 million at Collegium Pharmaceutical, up from $31.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding for COLL hit a ceiling of $40.7 million in Q4 2025 and a floor of -$2.5 million in Q1 2022.
  • Median Shares Outstanding over the past 5 years was $37.9 million (2023), compared with a mean of $33.7 million.
  • Biggest five-year swings in Shares Outstanding: crashed 106.92% in 2022 and later skyrocketed 1644.17% in 2023.
  • Collegium Pharmaceutical's Shares Outstanding stood at $35.8 million in 2021, then increased by 3.57% to $37.1 million in 2022, then grew by 2.99% to $38.2 million in 2023, then grew by 3.81% to $39.6 million in 2024, then rose by 2.75% to $40.7 million in 2025.
  • The last three reported values for Shares Outstanding were $40.7 million (Q4 2025), $40.6 million (Q3 2025), and $40.4 million (Q2 2025) per Business Quant data.